Prevalence and incidence rates of autism in the UK: Time trend from 2004-2010 in children aged 8 years

BMJ Open

Volumn 3, Issue 10, 2013, Pages

  Taylor, Brent ^a   Jick, Hershel ^b   MacLaughlin, Dean ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTISM; CHILD; DATA BASE; FEMALE; GENERAL PRACTICE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; UNITED KINGDOM;

EID: 84886707220     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003219     Document Type: Article

References (39)

1. CDC Division of News & Electronic Media (404) 639-3286. http://www.cdc.gov/media/releases/2012/p0329-autism-disorder.html
2. CDC Surveillance Summaries. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR 2012:61:3;1-19. http://www.cdc.gov/mmwr/preview/ mmwrhtml/ss6103a1.htm?s-cid=ss6103a1.
3. Jick H, Jick S, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
4. Jick H, Terris BZ, Derby LE, et al. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992;1:347-9.
5. Black C, Kaye JA, Jick H. Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. BMJ 2002;325:419-21. (Pubitemid 34969792)
6. Derby LE, Jick H, Henry DA, et al. Cholestatic hepatitis associated with flucloxacillin. Med J Aust 1993;158:596-600. (Pubitemid 23225274)
7. Melero Montes MM, Jick H. Hyperemesis gravidarum and the sex of the baby. Epidemiology 2000;12:123-4.
8. Kaye JA, Derby LE, Melero-Montes MM, et al. Breast cancer incidence among women aged 35 to 69 in the U.K. B comparison of estimates from the General Practice Research Database with cancer registration data. Br J Cancer 2000;83:1556-8.
9. Jick SS, Hagberg KW, Kaye JA, et al. Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer. Obstet Gynecol 2009;113:74-80.
10. Jick H, Chamberlin DP, Hagberg KW. The origin and spread of a mumps epidemic-United Kingdom, 2003-2006. Epidemiology 2009;20:656-61.
11. Jick H, MacLaughlin DS, Egger P, et al. The United Kingdom 2009 swine flu outbreak in real time. Epidemiol Res Int. Volume 2011. doi:10.1155/2011/381597
12. Fombonne E, Heavey L, Smeeth L, et al. Validation of the diagnosis of autism in general practitioner records. BMC Public Health 2004;4:5.
13. Smeeth L, Cook C, Fombonne E, et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 2004;364:963-9. (Pubitemid 39208457)
14. Kaye JA, Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001;322:460-3. (Pubitemid 32238805)
15. Jick H, Kaye JA, Black C. Changes in the risk of autism in the UK for birth cohorts 1990-1998. Epidemiology 2003;14:630-2. (Pubitemid 40417047)
16. Hagberg KW, Jick H. Autism in the UK for birth cohorts 1988-2001. Epidemiology 2010;21:426-7.
17. King M, Bearman P. Diagnostic change and the increased prevalence of autism. Int J Epidemiol 2009;38:1224-34.
18. Fisch GS. Nosology and epidemiology in autism: classification counts. Am J Med Genet C Semin Med Genet 2012;160C:91-103.
19. Liu KY, King M, Bearman PS. Social influence and the autism epidemic. AJS 2010;115:1387-434.
20. Taylor B. Vaccines and the changing epidemiology of autism. Child Care Health Dev 2006;32:511-19. (Pubitemid 44210089)
21. Yergin-Allsop M, Rice C, Karapurkar T, et al. Prevalence of autism in a US metropolitan area. JAMA 2003;289:49-55. (Pubitemid 36026277)
22. Department of Developmental Services. Changes in population of persons with autism and pervasive developmental disorders in California's Developmental Services System: 1987 through 1998: a report to the Legislature March 1, 1999. Sacramento: California Health and Human Services Agency, 1999.
23. Department of Developmental Services. Autism spectrum disorders: changes in the California caseload an update: 1999 through 2002. Sacramento, CA: Department of Developmental Services, California Health and Human Services Agency, 2003.
24. Dales L, Hammer SJ, Smith NJ. Time trends in autism and MMR immunisation in California. JAMA 2001;285:1183-5. (Pubitemid 32198484)
25. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002;347:1477-82. (Pubitemid 35257586)
26. Elsabbagh M, Divan G, Koh Y-J, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res 2012;5:160-79.
27. Keyes KM, Susser E, Cheslack-Postava K, et al. Cohort effects explain the increase in autism diagnosis among children born from 1992 to 2003 in California. Int J Epidemiol 2012;41:495-503.
28. Mazumdar S, King M, Liu K-Y, et al. The spatial structure of autism in California, 1993-2001. Health Place 2010;16:539-46.
29. Williams E, Thomas K, Sidebotham H, et al. Prevalence and characteristics of autistic spectrum disorders in the ALSPAC cohort. Dev Med Child Neurol 2008;50:672-7.
30. Baird G, Simonoff E, Pickles A, et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 2006;368:210-15. (Pubitemid 44037796)
31. Lord C. Epidemiology: how common is autism? Nature 2011;474:166.
32. Charman T, Pickles A, Chandler S, et al. Commentary: effects of diagnostic thresholds and research vs service and administrative diagnosis on autism prevalence. Int J Epidemiol 2009;38:1234-8.
33. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-41. (Pubitemid 28098447)
34. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026-9. (Pubitemid 29271747)
35. Taylor B, Miller E, Lingam R, et al. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 2002;324:393-6. (Pubitemid 34163901)
36. Lingam R, Simmons A, Andrews N, et al. Prevalence of autism and parentally reported triggers in a North East London population. Arch Dis Child 2003;88:666-70. (Pubitemid 36930300)
37. Carey M. A summary of the CDC autism prevalence report. 2012; 1-8. http://autismsciencefoundation.wordpress.com/2012/03/29/a-summary-of-the-cdc- autism-prevalence-report/
38. Jick H, Kaye JA, Black C. Incidence and prevalence of drug-treated attention deficit disorder in the UK. Br J Gen Pract 2004;54;345-7. (Pubitemid 38584858)
39. Jick H, Wilson A, Wiggins P, et al. Comparison of prescription drug costs in the United States and the United Kingdom, part 3: methylphenidate. Pharmacotherapy 2012;32:970-3.